Skip to main content

Table 3 Multiple regression model using as dependent variable percent of change in non-HDL cholesterol concentration

From: Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)

Variable

Beta coefficient ± standard error

p value

Constant

14.4 ± 2.6

< 0.001

BMI < 25 kg/m2

7.6 ± 3.6

0.036

Mixed hyperlipidemia

0.82 ± 0.2

0.003

Percent of change of triglycerides

0.68 ± 0.4

< 0.001

  1. Correlation coefficient = 0.647, r2 = 0.419, p = 0.001 BMI, Body mass index